S&P 500   4,000.70 (+0.52%)
DOW   31,722.10 (+0.45%)
QQQ   300.05 (+0.36%)
AAPL   155.44 (-0.33%)
MSFT   258.66 (+0.22%)
META   161.39 (+0.62%)
GOOGL   109.13 (-0.29%)
AMZN   129.65 (+0.13%)
TSLA   287.00 (+1.16%)
NVDA   138.36 (+0.89%)
NIO   17.48 (+0.00%)
BABA   90.00 (-0.66%)
AMD   82.34 (+3.43%)
T   16.88 (+0.06%)
MU   54.87 (-0.24%)
CGC   3.40 (-0.29%)
F   15.22 (-1.36%)
GE   73.77 (+0.26%)
DIS   112.55 (-0.12%)
AMC   8.60 (+2.50%)
PYPL   95.65 (+0.72%)
PFE   46.59 (+1.00%)
NFLX   227.07 (-0.83%)
S&P 500   4,000.70 (+0.52%)
DOW   31,722.10 (+0.45%)
QQQ   300.05 (+0.36%)
AAPL   155.44 (-0.33%)
MSFT   258.66 (+0.22%)
META   161.39 (+0.62%)
GOOGL   109.13 (-0.29%)
AMZN   129.65 (+0.13%)
TSLA   287.00 (+1.16%)
NVDA   138.36 (+0.89%)
NIO   17.48 (+0.00%)
BABA   90.00 (-0.66%)
AMD   82.34 (+3.43%)
T   16.88 (+0.06%)
MU   54.87 (-0.24%)
CGC   3.40 (-0.29%)
F   15.22 (-1.36%)
GE   73.77 (+0.26%)
DIS   112.55 (-0.12%)
AMC   8.60 (+2.50%)
PYPL   95.65 (+0.72%)
PFE   46.59 (+1.00%)
NFLX   227.07 (-0.83%)
S&P 500   4,000.70 (+0.52%)
DOW   31,722.10 (+0.45%)
QQQ   300.05 (+0.36%)
AAPL   155.44 (-0.33%)
MSFT   258.66 (+0.22%)
META   161.39 (+0.62%)
GOOGL   109.13 (-0.29%)
AMZN   129.65 (+0.13%)
TSLA   287.00 (+1.16%)
NVDA   138.36 (+0.89%)
NIO   17.48 (+0.00%)
BABA   90.00 (-0.66%)
AMD   82.34 (+3.43%)
T   16.88 (+0.06%)
MU   54.87 (-0.24%)
CGC   3.40 (-0.29%)
F   15.22 (-1.36%)
GE   73.77 (+0.26%)
DIS   112.55 (-0.12%)
AMC   8.60 (+2.50%)
PYPL   95.65 (+0.72%)
PFE   46.59 (+1.00%)
NFLX   227.07 (-0.83%)
S&P 500   4,000.70 (+0.52%)
DOW   31,722.10 (+0.45%)
QQQ   300.05 (+0.36%)
AAPL   155.44 (-0.33%)
MSFT   258.66 (+0.22%)
META   161.39 (+0.62%)
GOOGL   109.13 (-0.29%)
AMZN   129.65 (+0.13%)
TSLA   287.00 (+1.16%)
NVDA   138.36 (+0.89%)
NIO   17.48 (+0.00%)
BABA   90.00 (-0.66%)
AMD   82.34 (+3.43%)
T   16.88 (+0.06%)
MU   54.87 (-0.24%)
CGC   3.40 (-0.29%)
F   15.22 (-1.36%)
GE   73.77 (+0.26%)
DIS   112.55 (-0.12%)
AMC   8.60 (+2.50%)
PYPL   95.65 (+0.72%)
PFE   46.59 (+1.00%)
NFLX   227.07 (-0.83%)
NASDAQ:PPBT

Purple Biotech - PPBT Stock Forecast, Price & News

$2.20
-0.07 (-3.08%)
(As of 09/8/2022 10:46 AM ET)
Add
Compare
Today's Range
$2.19
$2.71
50-Day Range
$2.10
$2.69
52-Week Range
$2.10
$5.18
Volume
54,538 shs
Average Volume
30,921 shs
Market Capitalization
$38.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PPBT stock logo

About Purple Biotech (NASDAQ:PPBT) Stock

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.

Receive PPBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter.

PPBT Stock News Headlines

Purple Biotech ADRs Up 10%
Purple Biotech GAAP EPS of -$1.05
Purple Biotech Issues Letter to Shareholders
We Think Solid State (LON:SOLI) Can Stay On Top Of Its Debt
Purple Biotech Staggers on Trial Results
See More Headlines
Receive PPBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter.

PPBT Company Calendar

Last Earnings
8/04/2022
Today
9/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PPBT
Employees
19
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1 million
Book Value
$2.51 per share

Miscellaneous

Free Float
17,063,000
Market Cap
$38.70 million
Optionable
Optionable
Beta
2.06

Key Executives

  • Mr. Gil Efron CPA (Age 56)
    M.A., Chief Exec. Officer
    Comp: $458.38k
  • Dr. Michael Schickler Ph.D. (Age 64)
    Head of Clinical & Regulatory Affairs
    Comp: $281.57k
  • Mr. Ido Morpurgo (Age 49)
    VP Operations
  • Mr. Nir Livneh (Age 43)
    VP of Legal Affairs
  • Dr. Fabien Sebille Ph.D. (Age 48)
    Chief Bus. Officer













PPBT Stock - Frequently Asked Questions

How have PPBT shares performed in 2022?

Purple Biotech's stock was trading at $3.89 at the start of the year. Since then, PPBT shares have decreased by 41.6% and is now trading at $2.27.
View the best growth stocks for 2022 here
.

How were Purple Biotech's earnings last quarter?

Purple Biotech Ltd. (NASDAQ:PPBT) announced its earnings results on Thursday, August, 4th. The company reported ($0.20) earnings per share (EPS) for the quarter.

What is Purple Biotech's stock symbol?

Purple Biotech trades on the NASDAQ under the ticker symbol "PPBT."

Who are Purple Biotech's major shareholders?

Purple Biotech's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.08%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Purple Biotech?

Shares of PPBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Purple Biotech's stock price today?

One share of PPBT stock can currently be purchased for approximately $2.27.

How much money does Purple Biotech make?

Purple Biotech (NASDAQ:PPBT) has a market capitalization of $39.93 million and generates $1 million in revenue each year.

How can I contact Purple Biotech?

Purple Biotech's mailing address is ONE AZRIELI CENTER ROUND TOWER 132 MENACHEM BEGIN ROAD, TEL AVIV L3, 6701101. The official website for the company is www.kitovpharma.com. The company can be reached via phone at (723) 933-3121, via email at ir@kitovpharma.com, or via fax at 972-153-39333121.

This page (NASDAQ:PPBT) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.